John W. Campbell III

John W. Campbell III

Education

Duke University (A.B., 1979)
Yale Law School (J.D., 1982)

Bar Admissions

California

John Campbell has focused his practice on transactional matters, including venture capital finance, public and private offerings of securities by domestic and foreign issuers, and mergers and acquisitions.

Mr. Campbell serves as primary outside counsel to a number of public and privately held companies. He regularly represents boards of directors and management teams in complex and challenging transactional and governance matters. He has a deep expertise in SEC reporting matters that enables him to provide expert, practical advice. Mr. Campbell's practice experience includes semiconductors, optics, software, life sciences, finance, consumer products and media. His clients have included some of the largest and most successful companies in these sectors, as well as early stage ventures, as well as financial intermediaries who serve them.

In the merger and acquisitions area, Mr. Campbell has substantial experience in structuring and negotiating a wide variety of transactions involving strategic and financial buyers. He has worked on well over a hundred transactions, including public company mergers, tender offers, spin-offs, and other acquisitions and divestitures. Mr. Campbell’s transactions have ranged in size from less than $3 million to nearly $40 billion in industries such as semiconductors, life sciences, consumer, social media and internet.

In the capital markets area, Mr. Campbell has handled numerous public and private offerings of both debt and equity securities, representing issuers and underwriters. His transactions have ranged from IPOs to PIPEs to registered direct offerings to 144A offerings. He has also represented numerous emerging companies in private placements and venture financings.

Mr. Campbell served as co-chair of Morrison & Foerster's Life Science Group from 2004 through 2008. He was as a member of the supervisory board of VPSA, the manager of FCPR (formerly Viventure Partners), the venture capital and private equity division of Vivendi Universal.

Mr. Campbell is recommended as a leading lawyer by Chambers USA 2008-2015, Best Lawyers In America 2007-2013 and Super Lawyers 2006-2012.

InvenSense’s acquisition of the microphone business of Analog Devices.
Represented InvenSense, Inc. (NYSE:INVN), the leading provider of fully integrated motion processing solutions for mobile and consumer applications, in its acquisition of the microphone business of Analog Devices Incorporated.
Textainer’s IPO.
Represented Textainer Group Holdings, the world’s leading lessor of marine intermodal shipping containers, in its $150 million initial public offering.
Textainer’s Acquisitions of Capital Leasing and Amphicon.
Represented Textainer in its acquisitions of the marine container fleets of Capital Leasing and Amphicon International.
Westaff’s Acquisition by Select Staffing.
Represented Westaff, Inc. in its acquisition for cash and debt totaling $66 million by Select Staffing, Inc.
Wafergen Financings.
Represented Wafergen Bio-Systems, Inc. in registered direct and PIPE financing transactions as well as in financings effected through a special purpose R&D subsidiary formed to raise capital and conduct research in Malaysia.
CastTV’s acquisition by Tribune Company.
Represented CastTV, Inc., in its acquisition by Tribune Media Services, a subsidiary of the Tribune Company.
Aradigm Financings.
Represented Aradigm, Inc. in PIPE transaction and retirement of debt through a sale of equity to Novo Nordisk.
BetaWave Financings.
Represented Betawave in $25 million preferred stock PIPE transaction, $10 million convertible debt PIPE transaction, and several other financings.
Astellas’s acquisition of Agensys and product rights from Fibrogen.
Represented Astellas Pharma Inc., Japan's second-largest drug maker, in its $537 million acquisition of Agensys Inc., and its acquisition of rest of world rights to certain products being developed by FibroGen Inc. for $815 million.
Century Theatre’s acquisition by Cinemark.
Represented Century Theatres, Inc., and its parent Syufy Enterprises in its sale to Cinemark, Inc. and its private equity sponsor Madison Dearborn for $1.05 billion.
InvenSense Financings.
Represented InvenSense, the leading provider of fully integrated motion processing solutions for mobile and consumer applications, in raising $40 million in a series of venture capital financings.
Integrated Flow Systems acquisition by AIT.
Represented Integrated Flow Systems, LLC in its acquisition by Advanced Integrated Technologies and its private equity sponsor Sunrise Partners.
InvenSense IPO.
Represented InvenSense in $83 million initial public offering underwritten by Goldman Sachs and Morgan Stanley.
InvenSense follow-on offering.
Represented InvenSense in $111 million follow-on offering underwritten by Goldman Sachs and Morgan Stanley.
TOUT financings.
Represented Tout Industries, a leading social media video networking company, in its spin-out from SRI and Series A financing.
Epitomics financings.
Represented Epitomics, Inc., developer of monoclonal antibodies, in five rounds of venture financing and pending initial public offering in Taiwan.
Epitomics’ acquisition by Abcam PLC.
Represented Epitomics International, a leading manufacturer of monoclonal antibodies for biomedical and in-vitro diagnostic research, in its $170 million cash and stock acquisition by Abcam PLC
Telome Health financing.
Represented Telome Health and its founders in licensing of technology from UCSF and financing.
Leapfrog offering.
Represented Leapfrog Enterprises in shelf registration for secondary offering of securities.
InvenSense’s acquisition of the microphone business of Analog Devices.
Represented InvenSense, Inc. (NYSE:INVN), the leading provider of fully integrated motion processing solutions for mobile and consumer applications, in its acquisition of the microphone business of Analog Devices Incorporated.
Textainer’s IPO.
Represented Textainer Group Holdings, the world’s leading lessor of marine intermodal shipping containers, in its $150 million initial public offering.
Textainer’s Acquisitions of Capital Leasing and Amphicon.
Represented Textainer in its acquisitions of the marine container fleets of Capital Leasing and Amphicon International.
Westaff’s Acquisition by Select Staffing.
Represented Westaff, Inc. in its acquisition for cash and debt totaling $66 million by Select Staffing, Inc.
Wafergen Financings.
Represented Wafergen Bio-Systems, Inc. in registered direct and PIPE financing transactions as well as in financings effected through a special purpose R&D subsidiary formed to raise capital and conduct research in Malaysia.
CastTV’s acquisition by Tribune Company.
Represented CastTV, Inc., in its acquisition by Tribune Media Services, a subsidiary of the Tribune Company.
Aradigm Financings.
Represented Aradigm, Inc. in PIPE transaction and retirement of debt through a sale of equity to Novo Nordisk.
BetaWave Financings.
Represented Betawave in $25 million preferred stock PIPE transaction, $10 million convertible debt PIPE transaction, and several other financings.
Astellas’s acquisition of Agensys and product rights from Fibrogen.
Represented Astellas Pharma Inc., Japan's second-largest drug maker, in its $537 million acquisition of Agensys Inc., and its acquisition of rest of world rights to certain products being developed by FibroGen Inc. for $815 million.
Century Theatre’s acquisition by Cinemark.
Represented Century Theatres, Inc., and its parent Syufy Enterprises in its sale to Cinemark, Inc. and its private equity sponsor Madison Dearborn for $1.05 billion.
InvenSense Financings.
Represented InvenSense, the leading provider of fully integrated motion processing solutions for mobile and consumer applications, in raising $40 million in a series of venture capital financings.
Integrated Flow Systems acquisition by AIT.
Represented Integrated Flow Systems, LLC in its acquisition by Advanced Integrated Technologies and its private equity sponsor Sunrise Partners.
InvenSense IPO.
Represented InvenSense in $83 million initial public offering underwritten by Goldman Sachs and Morgan Stanley.
InvenSense follow-on offering.
Represented InvenSense in $111 million follow-on offering underwritten by Goldman Sachs and Morgan Stanley.
TOUT financings.
Represented Tout Industries, a leading social media video networking company, in its spin-out from SRI and Series A financing.
Epitomics financings.
Represented Epitomics, Inc., developer of monoclonal antibodies, in five rounds of venture financing and pending initial public offering in Taiwan.
Epitomics’ acquisition by Abcam PLC.
Represented Epitomics International, a leading manufacturer of monoclonal antibodies for biomedical and in-vitro diagnostic research, in its $170 million cash and stock acquisition by Abcam PLC
Telome Health financing.
Represented Telome Health and its founders in licensing of technology from UCSF and financing.
Leapfrog offering.
Represented Leapfrog Enterprises in shelf registration for secondary offering of securities.

John Campbell is recommended as a leading lawyer by Chambers USA 2015, Best Lawyers In America 2013 and Super Lawyers 2012.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2017 Morrison & Foerster LLP. All rights reserved.